Skip to main content
BioAdvance NewsPortfolio NewsRelmada Therapeutics

Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms

By October 19, 2016November 1st, 2024No Comments

Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms

See more here